HOWLWerewolf Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 16599
Ticker: HOWL
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-04-30
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: HOWL

Detail

Enriched 2026-08-14 20:47

Market cap: $18,559,983.31
Shares outstanding (class): 48,599,066
Shares outstanding (weighted): 48,599,066
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 14
Location: WATERTOWN, MA
Homepage: https://www.werewolftx.com
Description: Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Market cap and share counts drift.

Funds holding this security

4 funds · 4 positions · $1.08M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$727.5K	0.00%	873,745 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$286.6K	0.00%	344,231 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$62.4K	0.05%	75,000 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$416.30	0.00%	500 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERHOWL
FIGI_COMPOSITEBBG00QXQ9XK4
FIGI_SHARE_CLASSBBG00QXQ9XL3
CIK0001785530
ISINUS95075A1079
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.85
Model: deepseek
Rationale: Werewolf Therapeutics is a biopharmaceutical company developing novel therapeutics, fitting the biotechnology industry within healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.